Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Parathyroid Hormone (PTH) on Osseous Cavity

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University of Michigan
ClinicalTrials.gov Identifier:
NCT00277706
First received: January 12, 2006
Last updated: October 6, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
No publications provided by University of Michigan

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):